Where Will Biogen Be in 5 Years?

Where Will Biogen Be in 5 Years?

Source: 
Motley Fool
snippet: 
  • Aduhelm looks to be a failure for Biogen, but now lecanemab is showing potential.
  • The company may yet need to seek acquisitions to bolster its growth prospects.